Text size Jason Alden / Bloomberg Data on the Covid-19 vaccine in development by AstraZeneca and the University of Oxford published in The Lancet on Monday looked positive, but the stock fell after rising last week due to high expectations for the data. Shares of the US deposit receipt for …
Read More »
LONDON (Reuters) – An experimental vaccine developed by AstraZeneca and the University of Oxford against the new coronavirus produced an immune response in early-stage clinical trials, data showed on Monday, preserving hope that it could be in use by the end of the year. Called AZD1222, the vaccine has been …
Read More »
At least two experimental COVID-19 vaccines produced a T-cell response in participants in early-stage clinical trials, which may indicate a longer-lasting form of immunity than an antibody response. BioNTech BNTX, + 3.46% and Pfizer Inc. PFE, + 0.69% It said early Monday morning that an ongoing early-stage clinical trial for …
Read More »
LONDON (Reuters) – An experimental vaccine developed by AstraZeneca and the University of Oxford against the new coronavirus produced an immune response in early-stage clinical trials, data showed on Monday, preserving hope that it could be in use by the end of the year. Called AZD1222, the vaccine has been …
Read More »
LONDON (Reuters) – An experimental vaccine developed by AstraZeneca and the University of Oxford against the new coronavirus produced an immune response in early-stage clinical trials, data showed on Monday, preserving hope that it could be in use by the end of the year. Called AZD1222, the vaccine has been …
Read More »